CAS RN: 1431697-96-9

CCT 241533 hydrochloride

Product Availability

Choose a grade to view its available package options.

6 package records3 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251007 2mg / 5mg Out of stock 5-7 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260325 100mg Out of stock Inquiry
Batchno.20260601 10mg In stock Shanghai Inquiry
Batchno.20250523 250mg Out of stock Inquiry
Batchno.20260404 25mg In stock Shanghai Inquiry
Batchno.20250420 50mg In stock Shanghai Inquiry
  • Product code: starshine_CAS1431697-96-9
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1431697-96-9 / 4-fluoro-2-[4-[[(3S,4R)-4-(2-hydroxypropan-2-yl)pyrrolidin-3-yl]amino]-6,7-dimethoxyquinazolin-2-yl]phenol;hydrochloride

Standard CAS: 1431697-96-9 Multi CAS: No

Basic Information

CAS
1431697-96-9
Multi CAS
No
Molecular Formula
C23H28ClFN4O4
Molecular Weight
478.900000
Exact Mass
478.178311
SMILES
CC(C)([C@@H]1CNC[C@H]1NC2=NC(=NC3=CC(=C(C=C32)OC)OC)C4=C(C=CC(=C4)F)O)O.Cl
InChI
InChI=1S/C23H27FN4O4.ClH/c1-23(2,30)15-10-25-11-17(15)27-21-13-8-19(31-3)20(32-4)9-16(13)26-22(28-21)14-7-12(24)5-6-18(14)29;/h5-9,15,17,25,29-30H,10-11H2,1-4H3,(H,26,27,28);1H/t15-,17-;/m1./s1
InChIKey
LAKJUTZIXHTMPC-SSPJITILSA-N

Computed Properties

Structural Parameters

Heavy atom count
33
Aromatic heavy atom count
16
Fraction Csp3
0.39
Rotatable bonds
6
H-bond acceptors
8
H-bond donors
4
Molar refractivity
127.02
TPSA
108.76

LogP / Solubility

WLOGP
3.35
MLOGP
2.98
XLogP3
3.35
Consensus LogP
3.23
Log S (ESOL)
-4.88
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.91
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6.27
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3.26

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
4

Get In Touch

Contact Us